An observational study in Post Stroke Spastic Hemiplegia, sponsored by Suleyman Demirel University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-02-20.
Sponsored by Suleyman Demirel University · Observational
This study aims to evaluate patient adherence to botulinum toxin (BoNT-A) treatment and identify the factors contributing to its discontinuation.
This retrospective cohort study analyzed the medical records of patients who received at least one botulinum toxin treatment for post-stroke spasticity (PSS) from 2012 to 2024. Eighty-one enrolled patients responded to structured questions about their reasons for not consistently continuing BoNT-A treatment.
703 studies on the registry are indexed under Muscle Spasticity; 148 are open to participants now.
This study's enrollment of 81 is above the median of 60 across 162 observational studies indexed under Muscle Spasticity.
Browse Muscle Spasticity studies →Suleyman Demirel University is the lead sponsor of 123 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients were recruited from outpatient and inpatient clinics at a university's Physical Medicine and Rehabilitation department.
Exclusion Criteria:
Previous studies did not question why patients thought they did not benefit from the injection. For example, the expectations of patients who said they did not benefit were excessive.
Primary Outcome
Most PSS patients received only one BoNT-A injection over 12 years
Time frame: 2012-2024
Primary Outcome
The primary reason cited for discontinuing BoNT-A therapy was a lack of awareness about the necessity of ongoing treatment.
Time frame: 2012-2024
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — name surname mail
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Suleyman Demirel University